發(fā)布時(shí)間：2018-05-25 13:45

  本文選題：嗜酸乳桿菌上清 + 長(zhǎng)雙歧桿菌上清��； 參考：《天津醫(yī)科大學(xué)》2017年碩士論文

【摘要】：目的:腸易激綜合征(Irritable Bowel Syndrome,IBS)是一種以腹痛、腹脹、腹部不適為特征癥狀,常伴有排便頻率和(或)糞便性狀改變的臨床常見(jiàn)消化道功能性疾病。近年研究表明,5-羥色胺(5-hydroxytryp-tamine,5-HT)及其轉(zhuǎn)運(yùn)體(Serotonin Transporter,SERT)的代謝紊亂可能導(dǎo)致內(nèi)臟感覺(jué)異常、腸道運(yùn)動(dòng)紊亂,在IBS的發(fā)病中有重要作用。目前研究表明SERT表達(dá)的高低除受SERT基因多態(tài)性的影響外,還受腸道微生態(tài)的影響。大量臨床試驗(yàn)證明益生菌可以改善IBS患者腹痛、腹脹等癥狀,對(duì)于治療腸易激綜合癥療效顯著。乳酸桿菌和雙歧桿菌是IBS中最常研究的益生菌,其中嗜酸乳桿菌及長(zhǎng)雙歧桿菌已經(jīng)作為益生菌制劑應(yīng)用于臨床。然而益生菌制劑改善IBS癥狀的具體作用機(jī)制尚不明確。我們之前的研究表明鼠李糖乳桿菌上清可以上調(diào)腸道上皮細(xì)胞和小鼠結(jié)腸組織SERT的表達(dá),然而目前尚無(wú)研究證實(shí)嗜酸乳桿菌和長(zhǎng)雙歧桿菌上清是否也能夠調(diào)節(jié)SERT的表達(dá)。本研究的目的是觀察嗜酸乳桿菌和長(zhǎng)雙歧桿菌上清對(duì)腸道上皮細(xì)胞SERT mRNA及SERT蛋白的影響,從而為研究益生菌治療IBS作用機(jī)制提供新的理論依據(jù)。方法:本實(shí)驗(yàn)分別用1:100、1:50、1:20 3種不同稀釋濃度的嗜酸乳桿菌(ATCC4356)上清和長(zhǎng)雙歧桿菌(ATCC 15707)上清刺激HT-29和Caco-2細(xì)胞12小時(shí)和24小時(shí),然后應(yīng)用RT-PCR檢測(cè)細(xì)胞的SERT mRNA的表達(dá)水平變化,應(yīng)用Western-Blot檢測(cè)細(xì)胞的SERT蛋白的表達(dá)水平變化。統(tǒng)計(jì)學(xué)分析應(yīng)用SPSS 17.0統(tǒng)計(jì)軟件:用均數(shù)±標(biāo)準(zhǔn)差(±s)來(lái)表示計(jì)量資料。應(yīng)用單因素方差分析來(lái)比較3組以上計(jì)量資料的組間差異,用LSD方法檢驗(yàn)方差齊性數(shù)據(jù),用Dunnett方法檢驗(yàn)方差不齊數(shù)據(jù)。以P0.05表示差異有統(tǒng)計(jì)學(xué)意義。結(jié)果:1:100,1:50和1:20稀釋的嗜酸乳桿菌上清刺激HT-29細(xì)胞12小時(shí)和24小時(shí),刺激組SERT mRNA表達(dá)水平分別是對(duì)照組的1.80,2.24,2.28,和2.04,2.30,2.80倍(P0.05,P0.05,P0.05,和P0.05,P0.05,P0.05);1:100,1:50和1:20稀釋的嗜酸乳桿菌上清刺激Caco-2細(xì)胞12小時(shí)和24小時(shí),刺激組SERT mRNA表達(dá)水平分別是對(duì)照組的1.20,1.22,1.61,和1.16,1.50,2.13倍(P0.05,P0.05,P0.05,和P0.05,P0.05,P0.05);1:100,1:50和1:20稀釋的長(zhǎng)雙歧桿菌上清刺激HT-29細(xì)胞12小時(shí)和24小時(shí),刺激組SERT mRNA表達(dá)水平分別是對(duì)照組的0.96,1.90,2.50,和2.58,2.19,3.21倍(P0.05,P0.05,P0.05,和P0.05,P0.05,P0.05);1:100,1:50和1:20稀釋的長(zhǎng)雙歧桿菌上清刺激Caco-2細(xì)胞12小時(shí)和24小時(shí),刺激組SERT mRNA表達(dá)水平分別是對(duì)照組的1.25,2.06,1.83和1.84,2.23,2.13倍(P0.05,P0.05,P0.05,和P0.05,P0.05,P0.05)。各濃度嗜酸乳桿菌與長(zhǎng)雙歧桿菌上清均上調(diào)HT-29細(xì)胞和Caco-2細(xì)胞SERT蛋白的表達(dá),上調(diào)水平與相應(yīng)的mRNA上調(diào)水平大致相同。結(jié)論:(1)嗜酸乳桿菌及長(zhǎng)雙歧桿菌上清可以上調(diào)腸道上皮細(xì)胞SERTmRNA及SERT蛋白的表達(dá);(2)嗜酸乳桿菌及長(zhǎng)雙歧桿菌上清上調(diào)SERTm RNA和SERT蛋白的表達(dá)具有時(shí)間依賴(lài)性和濃度依賴(lài)性。
[Abstract]:Objective: Irritable Bowel Syndrome syndrome (IBS) is a common clinical gastrointestinal functional disease characterized by abdominal pain, abdominal distension and abdominal discomfort, often accompanied by defecation frequency and / or fecal changes. Recent studies have shown that the metabolic disorder of serotonin transporter serotonin (serotonin) and serotonin transporter (serotonin) may lead to visceral sensory disorder and intestinal motility disorder, which may play an important role in the pathogenesis of IBS. Current studies have shown that the expression of SERT is affected not only by the polymorphism of SERT gene, but also by intestinal microecology. A large number of clinical trials have proved that probiotics can improve abdominal pain, abdominal distension and other symptoms in patients with IBS, and it is effective in the treatment of irritable bowel syndrome. Lactobacillus and Bifidobacterium are the most commonly studied probiotics in IBS. Lactobacillus acidophilus and Bifidobacterium long have been used as probiotics in clinic. However, the mechanism of probiotics in improving IBS symptoms is unclear. Our previous studies have shown that the supernatants of Lactobacillus rhamnoides can up-regulate the expression of SERT in intestinal epithelial cells and colonic tissues of mice. However, there is no study on whether the supernatants of Lactobacillus acidophilus and Bifidobacterium can also regulate the expression of SERT. The purpose of this study was to observe the effects of supernatants of Lactobacillus acidophilus and Bifidobacterium longidus on SERT mRNA and SERT protein in intestinal epithelial cells, and to provide a new theoretical basis for studying the mechanism of probiotics in treating IBS. Methods: in this experiment, HT-29 and Caco-2 cells were stimulated with 1: 100 and 1: 50: 20 supernatants of 1: 100, 1: 50, 1: 20 with different diluted concentrations of Lactobacillus acidophilus (ATCC4356) and Bifidobacterium longidus (ATCC15707) for 12 and 24 hours, respectively. The expression of SERT mRNA was detected by RT-PCR. The expression of SERT protein was detected by Western-Blot. Statistical analysis using SPSS 17.0 statistical software: mean 鹵standard deviation (鹵s) to represent the measurement data. Univariate analysis of variance was used to compare the differences among three groups of measurement data. LSD method was used to test the homogeneity data of variance and Dunnett method was used to test the uneven data. The difference was statistically significant with P0.05. Results HT-29 cells were stimulated by the supernatant of Lactobacillus acidophilus diluted at 1: 1: 100 and 1:20 for 12 hours and 24 hours, respectively. The SERT mRNA expression levels in the stimulated group were 1.80 / 2.242.28 and 2.042.302.80 times as compared with those in the control group, respectively, and the Caco-2 cells were stimulated by the supernatants of P0.05P0.05P0.05P0.05P0.05P0.05: 50 and 1:20 diluted by Lactobacillus acidophilus for 12 hours and 24 hours, respectively, in which the supernatant of Lactobacillus acidophilus diluted at 1: 1: 50 and 1:20 stimulated Caco-2 cells for 12 hours and 24 hours, respectively. The expression levels of SERT mRNA in the stimulated group were 1.20 ~ 1.22 / 1.61, 1.16 ~ 1.50 ~ 1.50 ~ 2.13 times, P _ (0.05) P _ (0.05) P _ (0.05) and P _ (0.05) P _ (0.05) P ~ (0.05) respectively, and the supernatant of 1: 100: 1: 50 and 1:20 diluted bifidobacterium longus stimulated HT-29 cells for 12 and 24 hours, respectively. The expression levels of SERT mRNA in the stimulated group were 0.96 ~ 1.90 ~ 2.50, 2.58 ~ 2.19 and 3.21 times of the control group, respectively, and the levels of SERT mRNA expression in the stimulated group were as follows: P0.05, P0.05, P0.05, and P0.05P0.05, respectively, and the SERT mRNA expression levels in the stimulated group were 12 hours and 24 hours after the supernatant of P0.05: 100: 50 and 1:20 diluted by Bifidobacterium longii, respectively. The SERT mRNA expression levels in the stimulated group were 1.252.061.83 and 1.82.232.13 times of those in the control group, respectively. The levels of SERT mRNA expression in the stimulated group were 1.252.06.83 and 1.82.232.13 times that of the control group, respectively, and the expression levels of SERT mRNA in the stimulated group were 1.252.06.83 and 1.82.232.13 times as much as that in the control group. The supernatants of Lactobacillus acidophilus and Bifidobacterium longidus upregulated the expression of SERT protein in HT-29 and Caco-2 cells, and the up-regulation level was approximately the same as that of mRNA. Conclusion the supernatants of Lactobacillus acidophilus and Bifidobacterium longifera can up-regulate the expression of SERTmRNA and SERT protein in intestinal epithelial cells. The supernatants of Lactobacillus acidophilus and Bifidobacterium can up-regulate the expression of SERTm RNA and SERT proteins in a time-and concentration-dependent manner.
【學(xué)位授予單位】：天津醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R574.4

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 Duo-Chen Jin;Hai-Long Cao;Meng-Que Xu;Si-Nan Wang;Yu-Ming Wang;Fang Yan;Bang-Mao Wang;;Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome[J];World Journal of Gastroenterology;2016年36期

2 Tina Didari;Shilan Mozaffari;Shekoufeh Nikfar;Mohammad Abdollahi;;Effectiveness of probiotics in irritable bowel syndrome:Updated systematic review with meta-analysis[J];World Journal of Gastroenterology;2015年10期

3 張璐;段麗萍;劉懿萱;冷玉鑫;張華;劉作靜;王琨;;中國(guó)人群腸易激綜合征患病率和相關(guān)危險(xiǎn)因素的Meta分析[J];中華內(nèi)科雜志;2014年12期

4 Cong Dai;Chang-Qing Zheng;Min Jiang;Xiao-Yu Ma;Li-Juan Jiang;;Probiotics and irritable bowel syndrome[J];World Journal of Gastroenterology;2013年36期

5 王巧民;胡樂(lè)義;姜彬言;宋繼中;解朕;初晨;;利福昔明治療腹瀉型腸易激綜合征腸道菌群變化及療效觀察[J];中華消化雜志;2012年07期

6 王維達(dá);方秀才;朱麗明;費(fèi)貴軍;吳東;王智鳳;柯美云;;腸易激綜合征患者癥狀發(fā)作與飲食關(guān)系的調(diào)查[J];胃腸病學(xué);2012年02期

7 Roja Rahimi;Mohammad Abdollahi;;Herbal medicines for the management of irritable bowelsyndrome:A comprehensive review[J];World Journal of Gastroenterology;2012年07期

8 常穎;王邦茂;王玉明;;腸易激綜合征的遺傳易感性研究[J];國(guó)際消化病雜志;2011年05期

9 常媛媛;王邦茂;王玉明;張潔;蘇帥;;腸易激綜合征患者的精神心理因素與自主神經(jīng)功能紊亂[J];世界華人消化雜志;2011年03期

10 Roja Rahimi;Shekoufeh Nikfar;Ali Rezaie;Mohammad Abdollahi;;Effi cacy of tricyclic antidepressants in irritable bowel syndrome:A meta-analysis[J];World Journal of Gastroenterology;2009年13期

，

本文編號(hào)：1933332